careinfectious disease caresurgery & perioperative careportfolioinvestorspress releasesevents presentationsfinancial informationsec filingsannual and quarterly reportsstock informationtrading historyanalyst coverageinvestor faqinformation requestcareersour culturecareer opportunitiescontactglobal medical informationeducational grant requestsresearch proposals & grant requestspatient assistance programssearch the medicines company home aboutleadership team board of directors corporate governance corporate development productsu.s . marketed products globally marketed products pipelinecardiovascular care infectious disease care surgery & perioperative care portfolio investorspress releases events presentations financial informationsec filings annual and quarterly reports stock informationtrading history analyst coverage investor faq information request careersour culture career opportunities contactglobal medical information educational grant requests research proposals & grant requests patient assistance programs search search form search home slideshow http www.themedicinescompany.com investors news medicines company present data its investigational anesthetic mdco 700 anesthesiology http www.themedicinescompany.com investors news medicines company provides progress update ongoing orion 1 study pcsk9si http www.themedicinescompany.com investors news medicines company awarded 132 million develop portfolio new antibiotics targeting http www.themedicinescompany.com investors news medicines company provides update dyslipidemia programs previous pause next our company the medicines company aims to lead in acute and intensive care medicine worldwide . there is no higher priority for us than improving health outcomes for patients in ever more cost effective ways . today delivering authentic healthcare innovation worldwide is more challenging and complex than ever . it demands a sharp focus on what customers need . it requires the development and delivery of data knowledge and products that make a difference . clive meanwell ceo md phd recent news 13 oct 2016 the medicines company to present data from its investigational anesthetic mdco 700 at the anesthesiology 2016 annual meeting and the isap 25th annual meeting 5 oct 2016 the medicines company provides progress update on ongoing orion 1 study of pcsk9si see more careers we invite you to explore the medicines company . our success in the acute and intensive care setting truly depends on our collective contributions to a combined intelligence rigor energy and skill of the brightest and best in the world . learn more media media themedco.com investor relations krishna gorti md tel 973 290 6122 krishna.gorti themedco.com contact us the medicines company 8 sylvan way parsippany nj 07054 usa tel 973 290 6000 toll free 1 800 388 1183 fax 973 656 9898 careers contact us privacy policy disclaimer disclaimer privacy policy site map 2016 the medicines company